2020年雄激素性脱发的研究进展

doi:10.35541/cjd.20210362

摘要/Abstract

摘要： 【摘要】雄激素性脱发是一种遗传因素参与且依赖雄激素作用的特征性脱发，往往会对患者的身体形象及心理健康产生不利影响。本文综述2020年雄激素性脱发发病机制、诊断评估和临床治疗方面的研究进展。

Abstract: 【Abstract】 Androgenetic alopecia is a distinctive condition associated with genetic factors and effect of androgens, usually adversely affects the appearance and mental health of patients. This review summarizes research progress in the pathogenesis, diagnosis, evaluation and clinical treatment of androgenetic alopecia in 2020.

Key words: Alopecia, Diagnosis, Therapy, Androgenetic alopecia, Pathogenesis

邱月棨付思祺罗帅寒天李亚萍张桂英. 2020年雄激素性脱发的研究进展[J]. 中华皮肤科杂志, 2021, 54(9): 835-838.doi:10.35541/cjd.20210362

Qiu Yueqi, Fu Siqi, Luo Shuaihantian, Li Yaping, Zhang Guiying. Research advance in androgenetic alopecia in 2020[J]. Chinese Journal of Dermatology, 2021, 54(9): 835-838.doi:10.35541/cjd.20210362

参考文献 34

［1］	Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community⁃based study in six cities［J］. Br J Dermatol, 2010,162（4）:843⁃847. doi: 10.1111/j.1365⁃2133. 2010.09640.x.
［2］	中国医师协会美容与整形医师分会毛发整形美容专业委员会. 中国人雄激素性脱发诊疗指南［J］. 中国美容整形外科杂志, 2019,30（1）:6. doi: 10.3969/j.issn.1673⁃7040.2019.01.001.
［3］	Kobielak K, Pasolli HA, Alonso L, et al. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA［J］. J Cell Biol, 2003,163（3）:609⁃623. doi: 10.1083/jcb.2003 09042.
［4］	Higgins CA, Chen JC, Cerise JE, et al. Microenvironmental reprogramming by three⁃dimensional culture enables dermal papilla cells to induce de novo human hair⁃follicle growth［J］. Proc Natl Acad Sci U S A, 2013,110（49）:19679⁃19688. doi: 10.1073/pnas.1309970110.
［5］	Ceruti JM, Oppenheimer FM, Leirós GJ, et al. Androgens downregulate BMP2 impairing the inductive role of dermal papilla cells on hair follicle stem cells differentiation［J］. Mol Cell Endocrinol, 2021,520:111096. doi: 10.1016/j.mce.2020. 111096.
［6］	Belgardt E, Steinberg T, Husari A, et al. Force⁃responsive Zyxin modulation in periodontal ligament cells is regulated by YAP rather than TAZ［J］. Cell Signal, 2020,72:109662. doi: 10.1016/j.cellsig.2020.109662.
［7］	Wang Y, Gilmore TD. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear［J］. Biochim Biophys Acta, 2003,1593（2⁃3）:115⁃120. doi: 10.1016/s0167⁃4889（02）00349⁃x.
［8］	Liu Q, Shi X, Zhang Y, et al. Increased expression of Zyxin and its potential function in androgenetic alopecia［J］. Front Cell Dev Biol, 2020,8:582282. doi: 10.3389/fcell.2020.582282.
［9］	Seleit I, Bakry OA, Badr E, et al. Vitamin D receptor gene polymorphisms Taq⁃1 and Cdx⁃1 in female pattern hair loss［J］. Indian J Dermatol, 2020,65（4）:259⁃264. doi: 10.4103/ijd.IJD_482_18.
［10］	Hu S, Li Z, Lutz H, et al. Dermal exosomes containing miR⁃218⁃5p promote hair regeneration by regulating β⁃catenin signaling［J］. Sci Adv, 2020,6（30）:eaba1685. doi: 10.1126/sciadv.aba1685.
［11］	Deng W, Hu T, Han L, et al. miRNA microarray profiling in patients with androgenic alopecia and the effects of miR⁃133b on hair growth［J］. Exp Mol Pathol, 2021,118:104589. doi: 10.1016/j.yexmp.2020.104589.
［12］	Rakowska A, Slowinska M, Kowalska⁃Oledzka E, et al. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. Int J Trichology, 2009,1（2）:123⁃30. doi: 10.4103/0974⁃7753.58555.
［13］	Lee WS, Ro BI, Hong SP, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific （BASP） classification［J］. J Am Acad Dermatol, 2007,57（1）:37⁃46. doi: 10.1016/j.jaad.2006.12.029.
［14］	Chung Y, Lee SH, Choi SK. Fundamental basis of scalp layering techniques to protect against wound infection: a comparative study between conventional and in⁃to⁃out dissection of the superficial temporal artery［J］. World Neurosurg, 2017,97:304⁃311. doi: 10.1016/j.wneu.2016.10.002.
［15］	Soga S, Koyama T, Mikoshi A, et al. MR imaging of hair and scalp for the evaluation of androgenetic alopecia［J］. Magn Reson Med Sci, 2021,20（2）:160⁃165. doi: 10.2463/mrms.mp. 2020⁃0026.
［16］	Kerkemeyer KL, de Carvalho LT, Jerjen R, et al. Female pattern hair loss in men: a distinct clinical variant of androgenetic alopecia［J］. J Am Acad Dermatol, 2020,S0190⁃9622（20）32632⁃3. doi: 10.1016/j.jaad.2020.09.042.
［17］	Banihashemi M, Nahidi Y, Meibodi NT, et al. Serum vitamin D3 level in patients with female pattern hair loss［J］. Int J Trichology, 2016,8（3）:116⁃120. doi: 10.4103/0974⁃7753.188965.
［18］	York K, Meah N, Bhoyrul B, et al. A review of the treatment of male pattern hair loss［J］. Expert Opin Pharmacother, 2020,21（5）:603⁃612. doi: 10.1080/14656566.2020.1721463.
［19］	Nguyen D⁃D, Marchese M, Cone EB, et al. Investigation of suicidality and psychological adverse events in patients treated with finasteride［J］. JAMA Dermatol. 2021,157（1）:35⁃42. doi: 10.1001/jamadermatol.2020.3385.
［20］	Jimenez⁃Cauhe J, Saceda⁃Corralo D, Rodrigues⁃Barata R, et al. Characterization and management of hypertrichosis induced by low⁃dose oral minoxidil in the treatment of hair loss［J］. J Am Acad Dermatol, 2021,84（1）:222⁃223. doi: 10.1016/j.jaad.2020. 08.124.
［21］	Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety［J］. J Am Acad Dermatol, 2021,84（3）:737⁃746. doi: 10.1016/j.jaad.2020.06.1009.
［22］	Rodrigues⁃Barata R, Moreno⁃Arrones OM, Saceda⁃Corralo D, et al. Low⁃dose oral minoxidil for female pattern hair loss: a unicenter descriptive study of 148 women［J］. Skin Appendage Disord, 2020,6（3）:175⁃176. doi: 10.1159/000505820.
［23］	Dubin DP, Lin MJ, Leight HM, et al. The effect of platelet⁃rich plasma on female androgenetic alopecia: a randomized controlled trial［J］. J Am Acad Dermatol, 2020,83（5）:1294⁃1297. doi: 10. 1016/j.jaad.2020.06.1021.
［24］	Shapiro J, Ho A, Sukhdeo K, et al. Evaluation of platelet⁃rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial［J］. J Am Acad Dermatol, 2020,83（5）:1298⁃1303. doi: 10.1016/j.jaad.2020.07.006.
［25］	Zhou Y, Yu S, Zhao J, et al. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia［J］. Biomed Res Int, 2020,2020:1501893. doi: 10.1155/2020/1501893.
［26］	Shin H, Won CH, Chung WK, et al. Up⁃to⁃date clinical trials of hair regeneration using conditioned media of adipose⁃derived stem cells in male and female pattern hair loss［J］. Curr Stem Cell Res Ther, 2017,12（7）:524⁃530. doi: 10.2174/1574888X126 66170504120244.
［27］	Tak YJ, Lee SY, Cho AR, et al. A randomized, double⁃blind, vehicle⁃controlled clinical study of hair regeneration using adipose⁃derived stem cell constituent extract in androgenetic alopecia［J］. Stem Cells Transl Med, 2020,9（8）:839⁃849. doi: 10.1002/sctm.19⁃0410.
［28］	Uzel B, Takano G, Chartuni J, et al. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo⁃controlled trial［J］. Dermatol Ther, 2021,34（1）:e14622. doi: 10.1111/dth.14622.
［29］	Kutlu Ö. Dexpanthenol may be a novel treatment for male androgenetic alopecia: analysis of nine cases［J］. Dermatol Ther, 2020,33（3）:e13381. doi: 10.1111/dth.13381.
［30］	Kutlu Ö, Metin A. Systemic dexpanthenol as a novel treatment for female pattern hair loss［J］. J Cosmet Dermatol, 2021,20（4）:1325⁃1330. doi: 10.1111/jocd.13729.
［31］	Ismail FF, Meah N, Trindade de Carvalho L, et al. Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients［J］. 2020,83（5）:1478⁃1479. doi: 10.1016/j.jaad.2020.03.034.
［32］	Exicure and allergan enter into collaboration, option and license agreement to discover and develop sna⁃based treatments for hair loss disorders［EB/OL］. https://www.businesswire.com/news/home/ 20191114005106/en/Exicure⁃Allergan⁃Enter⁃Collaboration⁃Option⁃License⁃Agreement.
［33］	Lee J, Bӧscke R, Tang PC, et al. Hair follicle development in mouse pluripotent stem cell⁃derived skin organoids［J］. Cell Rep, 2018,22（1）:242⁃254. doi: 10.1016/j.celrep.2017.12.007.
［34］	Lee J, Rabbani CC, Gao H, et al. Hair⁃bearing human skin generated entirely from pluripotent stem cells［J］. Nature, 2020,582（7812）:399⁃404. doi: 10.1038/s41586⁃020⁃2352⁃3.

[1]	郭伟赵涛郭伟楠马翠玲高天文赵建红李冰. 早期甲黑素瘤115例手术治疗方案和预后回顾分析[J]. 中华皮肤科杂志, 2021, 54(9): 777-784.
[2]	王逸飞耿怡缪秋菊宋昊徐秀莲孙建方. 黏蛋白痣10例临床病理分析[J]. 中华皮肤科杂志, 2021, 54(9): 804-807.
[3]	中国医师协会皮肤科医师分会自身免疫性疾病学组. 环磷酰胺治疗自身免疫性皮肤病中国专家共识[J]. 中华皮肤科杂志, 2021, 54(9): 765-770.
[4]	中华医学会医学美学与美容学分会激光美容学组中华医学会皮肤性病学分会美容激光学组中国医师协会美容与整形医师分会激光学组. 中国痤疮瘢痕治疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(9): 747-756.
[5]	中华医学会皮肤性病学分会皮肤肿瘤研究中心中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤基底细胞癌诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(9): 757-764.
[6]	王大光蒋佳怡. 几种甲病诊疗的思考[J]. 中华皮肤科杂志, 2021, 54(8): 733-737.
[7]	宋志强顾恒. 加强皮炎湿疹类疾病诊断术语的规范化[J]. 中华皮肤科杂志, 2021, 54(8): 665-667.
[8]	中华医学会皮肤性病学分会皮肤肿瘤研究中心中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(8): 653-664.
[9]	宋歌梁官钊张美洁董嘉琤刘维达. 毳毛癣的临床诊治进展[J]. 中华皮肤科杂志, 2021, 54(8): 741-743.
[10]	郭丽芳葛一平杨寅林彤. 面部白癜风人工智能诊断模型的建立及评价[J]. 中华皮肤科杂志, 2021, 54(7): 586-589.
[11]	张磊尹盼盼周亚丽段仰灿. 乳房外Paget病的高频彩色多普勒超声特征分析[J]. 中华皮肤科杂志, 2021, 54(7): 625-628.
[12]	虞英媛李影余增洋郑建锋张希琳丁杨峰史玉玲. 英夫利西单抗治疗重度斑块状银屑病的疗效和安全性及其对PD-1、PD-L1表达的影响[J]. 中华皮肤科杂志, 2021, 54(7): 590-596.
[13]	张宇高迎霞顾宁琰朱虹陈京京胡清洁周敏段媛媛姚煦. 奥马珠单抗对慢性自发性荨麻疹患者的临床疗效和安全性分析[J]. 中华皮肤科杂志, 2021, 54(7): 582-585.
[14]	中华医学会皮肤性病学分会银屑病学组中华医学会皮肤性病学分会儿童学组. 中国儿童银屑病诊疗专家共识（2021）[J]. 中华皮肤科杂志, 2021, 54(7): 559-581.
[15]	曹珊杨宝琦. 疱疹样皮炎的研究进展[J]. 中华皮肤科杂志, 2021, 54(6): 549-553.